A. Gul et al., COAGULATION-FACTOR-V GENE MUTATION INCREASES THE RISK OF VENOUS THROMBOSIS IN BEHCETS-DISEASE, British journal of rheumatology, 35(11), 1996, pp. 1178-1180
We investigated the prevalence of the coagulation factor V gene G1691A
mutation in 64 patients with Behcet's disease (BD) and in 107 apparen
tly healthy individuals. The mutation was present in the heterozygous
state in 37.5% of the patients with a history of deep vein thrombosis
(12/32) and in 9.4% of the patients without any thrombotic event (3/32
). Eleven healthy individuals were also heterozygous for the mutation
(10.3%). The prevalence of the mutation in BD patients with and withou
t thrombosis was significantly different (P = 0.0079). We conclude tha
t the factor V gene mutation may play a major role in the development
of venous thrombosis in BD.